Clinical Trial Update: The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Central South University studying biomarkers of immunosuppressant metabolism in Chinese kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Central South University | Conditions: Kidney Transplantation | Phase 4 | Status: UNKNOWN